Government Owned Invention Available for License: Method of Manufacturing Papilloma Infiltrating Lymphocyte (PIL) Cell Therapy Products as a Treatment for Patients With Chronic Viral Infection(s)
Notice
Health and Human Services Department, National Institutes of Health
Notice
July 16, 2026
2026-14347
📄 Summary
The National Cancer Institute (NCI) seeks research co- development partners and/or licensees for development of papilloma- infiltrating lymphocytes (PIL) as treatment for patients with chronic human papillomavirus (HPV) 6 or 11 infections.
